Department of Pharmaceutical Sciences, Center for Drug Discovery, College of Pharmacy, Cancer Genes and Molecular Regulation Program, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, 68198-6805.
Med Res Rev. 2016 Jan;36(1):169-89. doi: 10.1002/med.21359. Epub 2015 Aug 31.
Natural products provide a successful supply of new chemical entities (NCEs) for drug discovery to treat human diseases. Approximately half of the NCEs are based on natural products and their derivatives. Notably, marine natural products, a largely untapped resource, have contributed to drug discovery and development with eight drugs or cosmeceuticals approved by the U.S. Food and Drug Administration and European Medicines Agency, and ten candidates undergoing clinical trials. Collaborative efforts from drug developers, biologists, organic, medicinal, and natural product chemists have elevated drug discoveries to new levels. These efforts are expected to continue to improve the efficiency of natural product-based drugs. Marinopyrroles are examined here as a case study for potential anticancer and antibiotic agents.
天然产物为药物发现提供了新的化学实体(NCEs)的成功来源,可用于治疗人类疾病。大约有一半的 NCEs 基于天然产物及其衍生物。值得注意的是,海洋天然产物是一个尚未充分开发的资源,已为药物发现和开发做出了贡献,有 8 种药物或化妆品已获得美国食品和药物管理局和欧洲药品管理局的批准,还有 10 种候选药物正在进行临床试验。药物开发商、生物学家、有机、药物和天然产物化学家的合作努力将药物发现提升到了新的水平。预计这些努力将继续提高基于天然产物的药物的效率。本文以海洋吡咯烷酮为例,研究其作为潜在抗癌和抗生素药物的可能性。